Among this five-peak panel, three (C3a-desArg, TTR and ApoH) were increased in sera of the breast cancer patients compared to that of HV subjects, while ApoCI and ApoAI were decreased in cancer. This evidence concerns the gene APOA1 and breast carcinoma.